Tubacex, S.A. Logo

Tubacex, S.A.

0KD1.L

(0.0)
Stock Price

2,95 EUR

2.99% ROA

21.34% ROE

13.74x PER

Market Cap.

417.764.952,00 EUR

43.98% DER

1.45% Yield

3.96% NPM

Tubacex, S.A. Stock Analysis

Tubacex, S.A. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Tubacex, S.A. Fundamental Stock Analysis
# Analysis Rating
1 ROE

Unidentified ROE

2 ROA

Unidentified ROA

3 PBV

Unidentified ROA

4 DER

Unidentified DER

5 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

6 Net Profit Growth

The net profit of this company has shown no signs of growth over the last five years, suggesting limited profitability and making it a less attractive investment opportunity.

7 Assets Growth

Company's revenue has stayed stagnant, showing no signs of improvement and making it a less favorable choice.

8 Graham Number

Unidentified Graham Number

9 Dividend Growth

The company's dividend growth has shown no improvement in the past three years, making it a less attractive investment option for those seeking increasing returns.

10 Dividend

No dividends from the company in the past three years raises doubts about its profitability for shareholders.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Tubacex, S.A. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Tubacex, S.A. Technical Stock Analysis
# Analysis Recommendation
1 Awesome Oscillator Hold
2 MACD Buy
3 RSI Hold
4 Stoch RSI Sell

Tubacex, S.A. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Tubacex, S.A. Revenue
Year Revenue Growth
2012 532.529.000
2013 556.806.000 4.36%
2014 549.452.000 -1.34%
2015 537.450.000 -2.23%
2016 498.813.000 -7.75%
2017 494.572.000 -0.86%
2018 625.828.000 20.97%
2019 618.444.000 -1.19%
2020 463.274.000 -33.49%
2021 343.542.000 -34.85%
2022 717.475.000 52.12%
2023 828.800.000 13.43%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Tubacex, S.A. Research and Development Expenses
Year Research and Development Expenses Growth
2012 250.000
2013 92.000 -171.74%
2014 2.510.000 96.33%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 534.000 100%
2023 0 0%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Tubacex, S.A. General and Administrative Expenses
Year General and Administrative Expenses Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Tubacex, S.A. EBITDA
Year EBITDA Growth
2012 45.783.000
2013 51.264.000 10.69%
2014 64.132.000 20.06%
2015 33.012.999 -94.26%
2016 28.247.000 -16.87%
2017 26.943.000 -4.84%
2018 69.121.000 61.02%
2019 52.528.000 -31.59%
2020 26.541.000 -97.91%
2021 10.196.000 -160.31%
2022 89.139.000 88.56%
2023 122.687.000 27.34%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Tubacex, S.A. Gross Profit
Year Gross Profit Growth
2012 215.669.000
2013 235.720.000 8.51%
2014 248.601.000 5.18%
2015 226.326.000 -9.84%
2016 223.818.000 -1.12%
2017 222.313.000 -0.68%
2018 302.088.000 26.41%
2019 279.481.000 -8.09%
2020 203.254.001 -37.5%
2021 170.171.000 -19.44%
2022 422.692.000 59.74%
2023 429.600.000 1.61%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Tubacex, S.A. Net Profit
Year Net Profit Growth
2012 11.863.000
2013 15.014.000 20.99%
2014 23.761.000 36.81%
2015 8.413.000 -182.43%
2016 507.000 -1559.37%
2017 -19.710.000 102.57%
2018 17.385.000 213.37%
2019 11.149.000 -55.93%
2020 -26.506.000 142.06%
2021 -35.945.000 26.26%
2022 20.234.000 277.65%
2023 31.200.000 35.15%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Tubacex, S.A. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2012 0
2013 0 0%
2014 0 0%
2015 0 0%
2016 0 0%
2017 0 0%
2018 0 0%
2019 0 0%
2020 0 0%
2021 0 0%
2022 0 0%
2023 0 0%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Tubacex, S.A. Free Cashflow
Year Free Cashflow Growth
2012 -34.397.000
2013 70.815.000 148.57%
2014 48.433.000 -46.21%
2015 37.084.000 -30.6%
2016 16.569.000 -123.82%
2017 -26.789.000 161.85%
2018 -43.221.000 38.02%
2019 20.966.000 306.15%
2020 -28.376.000 173.89%
2021 -42.350.000 33%
2022 68.152.000 162.14%
2023 0 0%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Tubacex, S.A. Operating Cashflow
Year Operating Cashflow Growth
2012 -993.000
2013 108.528.000 100.91%
2014 69.576.000 -55.98%
2015 62.206.000 -11.85%
2016 49.938.000 -24.57%
2017 2.205.000 -2164.76%
2018 -15.741.000 114.01%
2019 83.508.000 118.85%
2020 -8.828.000 1045.94%
2021 -23.925.000 63.1%
2022 87.610.000 127.31%
2023 0 0%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Tubacex, S.A. Capital Expenditure
Year Capital Expenditure Growth
2012 33.404.000
2013 37.713.000 11.43%
2014 21.143.000 -78.37%
2015 25.122.000 15.84%
2016 33.369.000 24.71%
2017 28.994.000 -15.09%
2018 27.480.000 -5.51%
2019 62.542.000 56.06%
2020 19.548.000 -219.94%
2021 18.425.000 -6.09%
2022 19.458.000 5.31%
2023 0 0%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Tubacex, S.A. Equity
Year Equity Growth
2012 251.954.000
2013 263.431.000 4.36%
2014 285.101.000 7.6%
2015 317.488.999 10.2%
2016 313.560.000 -1.25%
2017 281.814.999 -11.26%
2018 300.415.000 6.19%
2019 335.641.000 10.5%
2020 298.444.000 -12.46%
2021 249.189.000 -19.77%
2022 276.091.000 9.74%
2023 292.500.000 5.61%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Tubacex, S.A. Assets
Year Assets Growth
2012 675.281.000
2013 637.120.000 -5.99%
2014 700.268.000 9.02%
2015 859.124.000 18.49%
2016 851.801.000 -0.86%
2017 906.176.000 6%
2018 992.234.000 8.67%
2019 1.083.583.000 8.43%
2020 1.038.926.999 -4.3%
2021 1.041.791.999 0.28%
2022 1.159.779.000 10.17%
2023 1.149.000.000 -0.94%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Tubacex, S.A. Liabilities
Year Liabilities Growth
2012 423.327.000
2013 373.689.000 -13.28%
2014 415.167.000 9.99%
2015 541.635.000 23.35%
2016 538.241.000 -0.63%
2017 624.361.000 13.79%
2018 691.819.000 9.75%
2019 747.942.000 7.5%
2020 740.483.000 -1.01%
2021 792.603.000 6.58%
2022 883.688.000 10.31%
2023 856.500.000 -3.17%

Tubacex, S.A. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
6.9
Net Income per Share
0.26
Price to Earning Ratio
13.74x
Price To Sales Ratio
0.5x
POCF Ratio
0
PFCF Ratio
0
Price to Book Ratio
1.78
EV to Sales
0.34
EV Over EBITDA
2.42
EV to Operating CashFlow
0
EV to FreeCashFlow
0
Earnings Yield
0.07
FreeCashFlow Yield
0
Market Cap
0,42 Bil.
Enterprise Value
0,29 Bil.
Graham Number
3.39
Graham NetNet
-3.87

Income Statement Metrics

Net Income per Share
0.26
Income Quality
0
ROE
0.14
Return On Assets
0.04
Return On Capital Employed
0.2
Net Income per EBT
0.72
EBT Per Ebit
0.72
Ebit per Revenue
0.08
Effective Tax Rate
0.19

Margins

Sales, General, & Administrative to Revenue
0
Research & Developement to Revenue
0
Stock Based Compensation to Revenue
0
Gross Profit Margin
0.42
Operating Profit Margin
0.08
Pretax Profit Margin
0.06
Net Profit Margin
0.04

Dividends

Dividend Yield
0.01
Dividend Yield %
1.45
Payout Ratio
0
Dividend Per Share
0.05

Operating Metrics

Operating Cashflow per Share
0
Free CashFlow per Share
0
Capex to Operating CashFlow
0
Capex to Revenue
0
Capex to Depreciation
0
Return on Invested Capital
0.18
Return on Tangible Assets
0.03
Days Sales Outstanding
33.02
Days Payables Outstanding
245.95
Days of Inventory on Hand
407.49
Receivables Turnover
11.05
Payables Turnover
1.48
Inventory Turnover
0.9
Capex per Share
0

Balance Sheet

Cash per Share
1,09
Book Value per Share
1,98
Tangible Book Value per Share
1.5
Shareholders Equity per Share
1.98
Interest Debt per Share
0.87
Debt to Equity
0.44
Debt to Assets
0.09
Net Debt to EBITDA
-1.11
Current Ratio
0.97
Tangible Asset Value
0,18 Bil.
Net Current Asset Value
-0,21 Bil.
Invested Capital
0.44
Working Capital
-0,02 Bil.
Intangibles to Total Assets
0.1
Average Receivables
0,08 Bil.
Average Payables
0,25 Bil.
Average Inventory
405541500
Debt to Market Cap
0.25

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Tubacex, S.A. Dividends
Year Dividends Growth
2008 0
2009 0 0%
2013 0 0%
2014 0 0%
2015 0 0%
2019 0 0%
2023 0 0%

Tubacex, S.A. Profile

About Tubacex, S.A.

Tubacex, S.A., together with its subsidiaries, engages in the manufacture, supply, and sale of stainless steel and nickel super-alloy tubular solutions worldwide. The company offers seamless stainless steel tubes; mechanical tubes; round bars, billets, and ingots; fittings and special components, such as welding fittings, curved sections, elbows, tees, reducers, and caps; and Tubacoat, a ceramic coating for long steel and high-nickel alloy products. Its products have applications in oil and gas exploration and production, hydrocarbon processing, fertilizer, power generation, aerospace, and other industries. The company was incorporated in 1963 and is headquartered in Llodio, Spain.

CEO
Mr. Jesus Esmoris Esmoris
Employee
2.604
Address
Tres Cruces 8
Llodio, 01400

Tubacex, S.A. Executives & BODs

Tubacex, S.A. Executives & BODs
# Name Age
1 Mr. Javier Lorenzo Santiago
Managing Director of Americas
70
2 Mr. Celestino Danis Basurko
Managing Director of Steel & Extrusion
70
3 Mr. Manuel Sarabia Figueroa
HR Corporate Director and MD of Trading & Services
70
4 Mr. Guillermo Ruiz-Longarte Perez
Chief Corporate Officer
70
5 Mr. Ajay Sambrani
Managing Director of Asia & Middle East
70
6 Mr. Iker Azkargorta Viteri
Managing Director of Big Pipes & Fittings
70
7 Ms. Maider Cuadra Etxebarrena
Secretary
70
8 Mr. Diego Herrero De La Torre
Managing Director of Innovation Corporate
70
9 Mr. Jesus Esmoris Esmoris
Chief Executive Officer & Executive Director
70

Tubacex, S.A. Competitors